These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 6853137)

  • 1. Acetylator phenotype in rheumatoid arthritis.
    Ehrenfeld M; Zylber-Katz E; Levy M
    Isr J Med Sci; 1983 Apr; 19(4):368-70. PubMed ID: 6853137
    [No Abstract]   [Full Text] [Related]  

  • 2. Acetylator phenotype and the effect of dapsone in rheumatoid arthritis.
    Crook PR; Hortas C; Roberts EJ; Swinson DR; Mucklow JC; Shadforth MF
    J Rheumatol; 1983 Oct; 10(5):805-8. PubMed ID: 6644705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acetylator phenotyping in patients with malignant lymphomas, using caffeine as the metabolic probe.
    William BM; Abdel-tawab AM; Hassan EA; Mohamed OF
    Pol J Pharmacol; 2004; 56(4):445-9. PubMed ID: 15520499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Acetylator phenotype in spondylarthritis ankylopoietica].
    Rojkovich B; Genti G; Borbás E; Bálint G; Gömör B
    Orv Hetil; 1989 Dec; 130(49):2639-41. PubMed ID: 2689951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Distribution pattern of acetylator phenotypes: effect of age].
    Gachályi B; Vas A; Hajös P; Káldor A
    Orv Hetil; 1984 Jan; 125(2):75-7. PubMed ID: 6694835
    [No Abstract]   [Full Text] [Related]  

  • 6. Influence of acetylator phenotype and renal function on the antihypertensive effect of hydralazine.
    Koopmans PP; Hoefnagels WH; Huysmans FT; Thien T
    Neth J Med; 1984; 27(3):69-73. PubMed ID: 6709112
    [No Abstract]   [Full Text] [Related]  

  • 7. Acetylation of dapsone by human whole blood.
    Irshaid YM; al-Hadidi HF; Abuirjeie MA; Rawashdeh NM; Gharaibeh NS
    Int J Clin Pharmacol Ther Toxicol; 1993 Jan; 31(1):18-22. PubMed ID: 8444513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Acetylation phenotype in patients with systemic lupus erythematosus].
    Iakushkevich TN; Tareeva IE; Tuganbekova SK; Kovaleva VL; Evstaf'eva OL
    Ter Arkh; 1985; 57(8):82-4. PubMed ID: 3865448
    [No Abstract]   [Full Text] [Related]  

  • 9. Acetylator phenotype in Iraqi patients with discoid lupus erythematosus.
    Najim RA; Farid YY; Shihab SA
    Saudi Med J; 2004 Oct; 25(10):1530-2. PubMed ID: 15494852
    [No Abstract]   [Full Text] [Related]  

  • 10. Dapsone acetylation by human liver arylamine N-acetyltransferases and interaction with antiopportunistic infection drugs.
    Palamanda JR; Hickman D; Ward A; Sim E; Romkes-Sparks M; Unadkat JD
    Drug Metab Dispos; 1995 Apr; 23(4):473-7. PubMed ID: 7600914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [General acetylating capacity of the body of patients with rosacea].
    Alekseev IuV; Gladkikh SP; Mashkilleĭson AL; Altynbaeva RD; Evstaf'eva OL
    Vestn Dermatol Venerol; 1985 Oct; (10):21-2. PubMed ID: 2934906
    [No Abstract]   [Full Text] [Related]  

  • 12. Normal distribution of acetylation phenotypes in systemic lupus erythematosus.
    Vansant J; Woosley RL; John JT; Sergent JS
    Arthritis Rheum; 1978 Mar; 21(2):192-5. PubMed ID: 637885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pharmacokinetics of drug preparations metabolized by N-acetyltransferase].
    Skakun NP
    Klin Med (Mosk); 1982 Jan; 60(1):24-7. PubMed ID: 6122757
    [No Abstract]   [Full Text] [Related]  

  • 14. [Acetylation phenotype in atopic diseases].
    Patkowski J; Małolepszy J; Milejski P; Orzechowska-Juzwenko K; Nittner-Marszalska M
    Pol Tyg Lek; 1987 Jul; 42(29):870-3. PubMed ID: 3684766
    [No Abstract]   [Full Text] [Related]  

  • 15. [Hepatic acetylator phenotype in diabetic polyneuropathy].
    Ladero Quesada JM; Arrojo Romero A; Cocero Oviedo E; Gómez Pérez M; Cano Iglesias F; Franco Carcedo C; Camarero González E; Sánchez Creus P
    Rev Clin Esp; 1983 Mar; 168(6):399-402. PubMed ID: 6878767
    [No Abstract]   [Full Text] [Related]  

  • 16. Acetylator phenotype in Iraqi patients with systemic lupus erythematosus.
    Najim RA; Farid YY; Samad TA; Shihab SA
    East Mediterr Health J; 2005; 11(5-6):1003-8. PubMed ID: 16761671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Acetylation phenotype in patients with periodic disease].
    Podymov VK; Vinogradova OM; Kovaleva VL; Kochubeĭ LN; Galstian SM
    Ter Arkh; 1988; 60(6):93-5. PubMed ID: 2974645
    [No Abstract]   [Full Text] [Related]  

  • 18. Relationship between in vivo acetylator phenotypes and cytosolic N-acetyltransferase and O-acetyltransferase activities in human uroepithelial cells.
    Frederickson SM; Messing EM; Reznikoff CA; Swaminathan S
    Cancer Epidemiol Biomarkers Prev; 1994; 3(1):25-32. PubMed ID: 8118381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acetylator phenotyping: a comparison of the isoniazid and dapsone tests.
    Hanson A; Melander A; Wåhlin-Boll E
    Eur J Clin Pharmacol; 1981; 20(3):233-4. PubMed ID: 7286042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isoniazid acetylation phenotyping in Saudi Arabs.
    Matar KM; Mayet AY; Ayoola EA; Bawazir SA; Al-Faleh FZ; Al-Wazzan A
    J Clin Pharm Ther; 2004 Oct; 29(5):443-7. PubMed ID: 15482388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.